Chord Therapeutics

Cartesian Therapeutics

This clinical-stage biotechnology company develops mRNA cell therapies for patients with autoimmune diseases, including myasthenia gravis and myositis.

Toleranzia

This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.

Accure Therapeutics

This biopharmaceutical company develops central nervous system medicines to treat patients with conditions such as multiple sclerosis, Parkinson's disease, epilepsy and optic neuritis.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

NMD Pharma

This company develops small molecule therapies for patients suffering from severe neuromuscular disorders to restore skeletal muscle function.

Noema Pharma

This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.

Pheno Therapeutics

This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.

NovaGo Therapeutics

This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.